1d
U.S. IPO Weekly Recap: Biotech, Early-Stage Mining, And Bill Ackman Close Out The April IPO Market
Coagulation disorder biotech Hemab Therapeutics (COAG) upsized and priced at the high end to raise $302 million at an $849 ...
Renaissance Capital, which regularly takes the pulse of new stock issues, said April will be one of the biggest months for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results